Japan’s foray into regenerative medicine takes on added importance for a nation wrestling with age, stagnation, and its place ...

A team of scientists from the San Raffaele-Telethon Institute for Gene Therapy (SR-Tiget) in Milan, Italy, has identified a ...

Researchers have developed a vascularized organoid model of hormone secreting cells in the pancreas. The advance promises to improve diabetes research and cell-based therapies.

A research team led by Associate Professor Makoto Ikeya in the Department of Clinical Application at Kyoto University has ...

May 16, 2025 — Researchers have developed a method to confidently produce blood cell precursors from stem cells in mice, by activating a set of seven key genes in ... New Stem Cell Model Sheds ...

A team of scientists from the San Raffaele-Telethon Institute for Gene Therapy (SR-Tiget) in Milan, Italy, has identified a ...

Researchers from the Stem Cells and Cancer team at the Josep Carreras Leukaemia Research Institute and the Hospital del Mar Research Institute have developed a method to confidently produce blood cell ...

Stem cell therapy is an emerging treatment for type 2 diabetes. Although it’s not yet FDA-approved in the United States, it is a rapidly expanding and promising field of research. Stem cells are ...

This hybrid technology has the potential to transform treatments for neurodegenerative diseases by enhancing the precision and efficacy of stem cell-based therapies. The study's core innovation ...

Investors now have three ASX-listed stem cell therapy companies to choose from – and we can thank Mesoblast for inspiring the third.